Vimarsana
Biggest News Aggregation in the World

Page 7 - One Partnering News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from One Partnering. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In One Partnering Today - Breaking & Trending Today

Lutris Pharma to Participate in Virtual Investor Conferences in January - Vimarsana News

Lutris Pharma to Participate in Virtual Investor Conferences in January

/PRNewswire/ -- Lutris Pharma, a clinical stage biopharmaceutical company focused on improving anti-cancer therapies by reducing dose limiting side effects,...

Lutris Pharma to Participate in Virtual Investor Conferences in January - Vimarsana News

Lutris Pharma to Participate in Virtual Investor Conferences in January

TEL AVIV, Israel, Jan. 4, 2022 /PRNewswire/ -- Lutris Pharma, a clinical stage biopharmaceutical company focused on improving anti-cancer therapies by reducing dose limiting side effects, today

Viking Therapeutics Reports Third Quarter 2021 Financial Results and Provides Corporate Update - Vimarsana News

Viking Therapeutics Reports Third Quarter 2021 Financial Results and Provides Corporate Update

/PRNewswire/ -- Viking Therapeutics, Inc. (Viking) (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for...

AXON Neuroscience SE: Axon Neuroscience to Present at 2021 BIO Digital - Vimarsana News

AXON Neuroscience SE: Axon Neuroscience to Present at 2021 BIO Digital

Axon Neuroscience to present its 2nd generation COVID-19 monoclonal antibody ACmab1 at the premier biotech eventACmab1 has a superior efficacy and cost profile compared to other antibody therapies in developmentNEW

Annovis Bio, Inc.: Annovis Bio to Present at 2021 BIO Digital - Vimarsana News

Annovis Bio, Inc.: Annovis Bio to Present at 2021 BIO Digital

Berwyn, Pennsylvania--(Newsfile Corp. - June 10, 2021) - Annovis Bio, Inc. (NYSE American: ANVS), ("Annovis" or the "Company"), a clinical-stage drug platform company addressing Alzheimer's disease (AD)